Matthias Wiedenfels

Matthias Wiedenfels is Chief Executive Officer at BioCopy AG since 2023.
Holds the position of Chairman-Supervisory Board at APONTIS PHARMA AG since 2021.
Serves as Managing Director at Digithep GmbH.
Member of the Management Board at STADA Lux SARL. Member of the Supervisory Board at Spirig HealthCare AG, Pegach AG, Healgen Medical AG, and Biomedion Holding GmbH.
Formerly Chairman-Executive Board and Chief Executive Officer at STADA. Arzneimittel AG from 2016 to 2017.
Former Chief Executive Officer at Perspix Biotech GmbH.
Former Attorney at Ashurst LLP.
Former Member of the Management Board at BioMedion GmbH.
Education includes a doctorate from the University of Freiburg, and graduate degrees from Université de Montpellier and Ruprecht-Karls-Universität Heidelberg.